Cayman’s fully integrated bioanalysis and assay development services leverage the diverse expertise of our scientists to aid your research and/or drug discovery efforts at various stages, including biomarker discovery and development, target identification, hit identification and lead discovery, in vitro and mechanistic studies, and more. We can support projects ranging in scope from running or optimizing a single assay to building a comprehensive biomarker discovery and development program that leverages our numerous in-house capabilities and core facilities. As a contract research organization (CRO) with in-house experts in immunology, biochemistry, cell biology, molecular biology, biomarker development, cellular metabolism, and custom protein and antibody production, we offer a vast array of services and solutions to advance your project.
Use the links below to explore our individual service offerings and core capabilities.
Our sample analysis team draws on years of experience to detect specific analytes in biological samples and provide you with the highest quality data for your project.
Our flexible formats and automated workflows allow us to provide robust data you can trust.

We utilize standardized bioanalytical methods and provide industry-leading expertise in lipid biosynthetic pathways to support biomarker discovery and validation.
Our immunology team applies experience in a wide range of areas to bring you solutions in immune-mediated disease and immuno-oncology applications.
With expertise in neutrophil biology and isolation as well as NETosis induction, clearance, and inhibition assays, our scientists can detect NET formation and screen for modulators of NETosis using high-content imaging and NET-associated enzyme activity assays.
We offer a full suite of immunological assays, from primary cell isolation and phenotyping using flow cytometry, to ELISpot analysis (cytokine and immunoglobulin), cell-mediated cytotoxicity studies, and cytokine release assays (including multiplexed analysis). Custom assay development available.
We offer industry-leading optimized protocols and expertise for MS-based immunopeptidome profiling and neoantigen discovery with our partner MS Bioworks.
Learn MoreExplore therapeutic avenues in various disease models using high-content imaging, enzymatic screening, and the Agilent SeahorseTM XF platform.

With support from our core facilities and through our partnership with MS Bioworks, we offer full-service targeted and untargeted conventional and mass spectrometry-based proteomics services from immunoprecipitation and other sample prep to data analysis.
Along with our extensive catalog of commercial assays, Cayman offers custom assay design, development, validation, and manufacturing. Supported by our core facilities, we can build robust quantitative assays on a variety of analysis and detection platforms to suit your specific target and application. We follow industry-standard best practices that are the foundation of decades of commercial assay kit development and manufacturing. Fit-for-purpose characterization ensures that your custom assay is well suited to meet your specific needs. We can also provide enhanced documentation to support technology and/or method transfer to CLIA/CAP certified diagnostic testing labs.
We can develop assays in all of the areas for which we perform sample analysis. Available formats for custom assays include, but are not limited to:
Our scientists have experience creating assays for viability, immunology (including cytokine release), cellular metabolism, oxidative stress, GPCR signaling, nuclear receptor and transcription factor activation, transporter and ion channel function, and more.
Contact us to learn more about our capabilities and available platforms and discuss how Cayman can help meet your assay development needs.

Our bioanalysis and assay development services are supported by core competencies in protein expression and purification, antibody production, and cell and molecular biology.
The case study Cryo-EM and SPR Analysis of SARS-CoV-2 Spike Protein Neutralization by Cayman Antibody Complex was made possible by collaboration between our scientists in Antibody Production, Protein Production, and Structural Biology.
DOWNLOAD THE STUDYRead interviews with the experts behind our services.